Pipeline Watch
05 February 2010
This week’s Pipeline Watch is dominated by the recent raft of Japanese approvals (reported in full in Scrip issue 3481) and the initiation of Phase II clinical trials for seven new product candidates, including four for cancer indications. This includes Boehringer Ingelheim’s BI-6727, which...
Please Login to read the full article.
05 February 2010
This week’s Pipeline Watch is dominated by the recent raft of Japanese approvals (reported in full in Scrip issue 3481) and the initiation of Phase II clinical trials for seven new product candidates, including four for cancer indications. This includes Boehringer Ingelheim’s BI-6727, which...
Please Login to read the full article.
RELATED CONTENT
EVENTS
09 February 2012
London
28 February 2012
Pestana Chelsea Bridge Hotel London
04 March 2012
The Marriott World Center, Orlando, Florida
JOB OF THE WEEK
Promote your vacancy here
